0000899243-23-013912.txt : 20230525
0000899243-23-013912.hdr.sgml : 20230525
20230525183749
ACCESSION NUMBER: 0000899243-23-013912
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230523
FILED AS OF DATE: 20230525
DATE AS OF CHANGE: 20230525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: M28 Capital Management LP
CENTRAL INDEX KEY: 0001807489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40703
FILM NUMBER: 23962464
BUSINESS ADDRESS:
STREET 1: 700 CANAL STREET, 2ND FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-516-3730
MAIL ADDRESS:
STREET 1: 700 CANAL STREET, 2ND FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elia Marc
CENTRAL INDEX KEY: 0001830496
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40703
FILM NUMBER: 23962465
MAIL ADDRESS:
STREET 1: C/O SQZ BIOTECHNOLOGIES COMPANY
STREET 2: 200 ARSENAL YARDS BOULEVARD, SUITE 210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Invivyd, Inc.
CENTRAL INDEX KEY: 0001832038
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851403134
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 178
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 819-0080
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 178
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Adagio Therapeutics, Inc.
DATE OF NAME CHANGE: 20201112
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-23
0
0001832038
Invivyd, Inc.
IVVD
0001830496
Elia Marc
C/O INVIVYD, INC.
1601 TRAPELO ROAD, SUITE 178
WALTHAM
MA
02451
1
0
0
1
See Remarks
0001807489
M28 Capital Management LP
700 CANAL STREET, 2ND FLOOR
STAMFORD
CT
06902
0
0
0
1
See Remarks
0
Stock Option (Right to Buy)
1.70
2023-05-23
4
A
0
50000
0.00
A
2033-05-22
Common Stock
50000
50000
D
This option was granted on May 23, 2023 and vests in full upon the earlier of (i) May 23, 2024 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date. The grant was awarded to Marc Elia ("Mr. Elia"). Mr. Elia is deemed to hold the grant for the benefit of M28 Capital Management LP ("M28 Capital Management") and the funds managed by M28 Capital Management.
M28 Capital Management may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, by virtue of the fact that Mr. Elia, who indirectly controls M28 Capital Management, currently serves on the board of directors of the Issuer. The Reporting Persons expressly disclaim beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any.
/s/ Jill Andersen attorney-in-fact for Marc Elia
2023-05-25
M28 Capital Management LP, By: /s/ Chris Taliercio
2023-05-25